• Human immunodeficiency virus, or HIV, is the virus that causes acquired immune deficiency syndrome (AIDS). The virus weakens a person’s immune system so they are not able to fight infections or cancer as effectively. Having HIV does not always mean you have AIDS, as it can take many years for people with HIV to develop AIDS.


    HIV targets a type of white blood cell called a CD4 cell, which it attacks and destroys. CD4 cells are important for fighting disease, and when a person’s CD4 cell count is too low, they are more susceptible to illness.


    HIV is contracted when infected bodily fluids such as blood, semen, fluids from the vagina, or breast milk enter a person’s blood stream. It is commonly a sexually transmitted disease, but can occur when needles are not cleaned properly or are shared. It can also enter the body through broken skin. In addition, a pregnant woman with HIV can spread the virus to her baby.


    Symptoms of HIV generally appear after a person’s immune system has been weakened. The symptoms are:


    Fatigue and lack of energy

    Unexplained weight loss

    Frequent fevers or sweats

    Persistent or frequent yeast infections

    Persistent skin rashes

    Short term memory loss

    Mouth, genital, or anal sores from herpes infections

    Once a person develops AIDS, meaning their CD4+ cell count is below 200 per microliter of blood, the whole body and nearly every organ can be affected. The person can have the following symptoms:


    Cough/shortness of breath

    Seizures

    Difficult or painful swallowing

    Mental symptoms (confusion, forgetfulness)

    Severe and persistent diarrhea

    Fever

    Vision loss

    Nausea, abdominal cramps, bloating

    Weight loss and extreme fatigue

    Severe headaches

    Coma

    HIV/AIDS medications are very powerful and often produce powerful side effects. They include:

    Anemia

    Diarrhea and abdominal pain

    Nausea

    Vomiting

    Fatigue

    Dizziness

    Chills

    Anxiety

    Rash

    Depression

    Difficulty sleeping

    Headache

    While the effects of cannabinoids have not been studied for all of these symptoms and side effects, there are many reports that cannabinoids can be beneficial, either lessening the symptoms of the disease itself, or the side effects of the medication. Cannabinoid solutions seems to have a positive effect on stomach upset, abdominal pain, nausea/vomiting, difficulty sleeping, anxiety, and headaches.


    In addition, TAT (Trans-Activator of Transcription), an HIV gene, has been shown by researchers at the Mount Sinai School of Medicine to be inhibited by cannabinoids. HIV has been able to mutate and reproduce itself despite the use of antiretroviral drugs. Soon, the HIV in countless numbers of patients will be resistant to conventional treatments, a huge problem for the whole world. Cannabis Science has begun a drug development program to target this problem, using cannabinoids to inhibit TAT.


    Cannabis Sciences’s work with cannabinoids in relation to HIV/AIDS will create more scientific studies and information for the public and medical community’s general knowledge about cannabinoid solutions.



  • Category
    Critical Ailments
  • Created
    Thursday, 16 March 2017
  • Group admin
    CBIS

American States University

 CSi_Updates_Outline2.jpgDrug Valuation Image3


 

 Recent GBXI News:

June 22, 2023, GBX International Group, Inc., (OTC: GBXI)
Breaking Cancer Barriers; Investments in Low-Cost, Harvard Award-Winning, Effective Cancer Killing Drugs Now; GBXI Proceeds to Raise $1 Million to Fast-Track its' Success, Cancer Drug Valuations, Access for Patients, Full Company Audit, and Accelerate the Trading of the CSi-Spinout Shares

 

May 11, 2023, GBX International Group, Inc., (OTC: GBXI)
GBX International Group, Inc. (OTC:GBXI) Confirms 2023 Strong Revenue Growth Guidance Projections by Combining Each Acquired Operating Company Product Release, Expects Strong Growth Sector by Sector Through its Multiple Product Releases into North American and International Markets


April 21, 2023, GBX International Group, Inc., (OTC: GBXI)

HARVARD Award Winning Entrepreneur, Mr. Raymond C. Dabney Acquires Majority Shareholder Control of GBX International Group, Inc. (OTC: GBXI) Makes More History Bringing CSi-EDP Partner American States University (ASU) as the First Acquisition for its Aggressive Growth Plans 



Harvard GHC Award RCD 2018

 

The ASU Digital Business HUB will be used as the main business student learning center. GBXI will be the main pivot point to spin out trading shares of all our Partner Public and Private Companies such as Cannabis Science, iCannabinoid, Thermic Science, LNC, LMG, and a few more old and new school surprises for our loyal shareholders. No one will be missed! A true Digital Business HUB for students, just as planned all along.

Each spinout company will give our GBXI registered shareholders additional pro-rata shares in each spinout company over and above their original shares in each entity. This provides the required shareholder base for each company required to trade and gives additional shares to all our loyal GBXI shareholders.

We call this “Compounding our Wealth” through extra spinout share participation for all our loyal GBXI shareholders. Each registered GBXI shareholder will receive additional shares of each spinout Company over and above their original shares to enjoy additional liquidity as each company begins to trade through the GBXI Digital Business HUB spinout process.

 

Click here to review the Report:

Frontiers Capture
1mmStrong July 8 Court UPDATE Brochure Image

Sac Court Capture

Case No. 2:17-CV-02271-KJM-JDP



Inspire, Dream, Change

YOUR DIGITAL ERA Personal & Business Access Learning HUB
 



Observational Studies

PART

Notifications

Activity Stream

Hi Raymond,

As a long-standing Loyal Shareholder, I hope that this posting finds you in good health and good spirits. I made my first CBIS purchase...
Show more

Francis Cormier What I am waiting for is the Announcement for the Upcoming Public Fundraising Event reported previously; to be happening with a TBD date. I am... Show more 6 days ago
loader
loader
Attachment
RENE RAMIREZ How about a chart that shows action items with status and anticipated completion dates, yesterday
loader
loader
Attachment
grant r smith raymond - are the new shares that will be issued to us as each company comes online come to us before or after they start trading? 12 hours 43 minutes ago
loader
loader
Attachment
Raymond C. Dabney Great clarity question Grant, Thanks. As you see from the list there are several classes of shares on our Group:

1. Original CBIS, everyone has...
Show more
7 hours 41 minutes ago
loader
loader
Attachment
KELLY PINGSTERHAUS Thank you Raymond for the update. News and information is always welcome for it is all we get to see, whereas you see everything that is happening... Show more 5 hours 55 minutes ago
loader
loader
Attachment

Cannabis Science Inc. "Shareholder Loyalty Gift Center of Excellence"

HARVARD Award Winning 
CANCER Killing Success





1st HARVARD Award Winning
Stage 4 Lung Cancer Killing Article:
*** Please click image below.

Frontiers_1.JPG


2nd HARVARD Award Winning
Stage 4 Lung Cancer Killing Article:
*** Please click image below.

 Frontiers_2.JPG


*** PLUS

(3) other Cannabis Science
REAL WORLD Successes:

Stage 4 Breast Cancer

WhatsApp_Image_2022-05-21_at_9.37.37_AM_3.jpg
Skin Cancer 

WhatsApp_Image_2022-05-21_at_9.37.38_AM.jpeg
Karposis Sarcoma

WhatsApp_Image_2022-05-21_at_9.37.38_AM_1.jpeg

CSi Final GIFT Share Issuance Nov 27 2022



Cannabis Science CEO, Presents …

The FINAL “CBIS GIFT Shares” Issuances!

DECEMBER 1, 2022, Cheers! & HAPPY HOLIDAYS !!!

ALL GIFT Shares 1, 2, & 3 being ISSUED !!!

 LAST Steps:

Please confirm Yours NOW !!!

1. CONFIRM Correct Total Share Amount(s)

2. CONFIRM Correct Name(s) on CERTIFICATE

3. CONFIRM Correct Mailing Address

ASU/CSi-EDP-ECO-System
At it's FINEST !!! 

WHICH ONE ARE YOU ??

Those who, MAKE things happen.
Those who WATCH things happen.
Those who WONDER what the ... HAPPENED ???

We can make this HAPPEN way FASTER Working as a TEAM !!!

WHAT Matters is how much you CARE about KILLING CANCERS ...

This is it ... We are ALL Here ... Now ... with a Bunch of Celebrities going on TV Worldwide to Start raising $20 Million to Keep Killing Cancers.



2023 Audit considerations NASDAQ.

Cannabis Science Inc.
Share Structure 2023

Par Value: $0.001 USD
Last Price: $0.00647 USD
OTC Markets.

Common Stock:
Authorized:
5,000,000,000
Issued:
2,521,095,296

Class A Common Stock
Authorized:
100,000,000
Issued:
0

Class B Common Stock
Authorized:
1,500,000,000
Issued:
0

Preferred Stock
Authorized:
1,000,000
Issued:
1,000,000



Sign up for a FREE Assessment to JOIN the UNIVERSITY Team or any ASU/CSi-EDP Team for whatever your AREA of Expertise is … then say no more… you already know.

You already know our Extensive LIST of GROUNDBREAKING Products.

1-Million STRONG TV Coverage, HARVARD Award Success.

TAKE YOUR PICK AND BECOME A PART OF HISTORICAL CHANGE




*** APPLY for FREE in CONFIDENCE and Success.

Each Product launch WE RELEASE will include Equity Participation according to standard salaries and share bonus structures.

EVERYONE sign up to add your STRENGTHS to OUR COMBINED SUCCESS and lets MAKE THIS HAPPEN NOW !!!

 

Events

Sorry, we currently have no events.
View All Events